Your Health Plan:
Your Health Plan:
Not SelectedBYETTA (exenatide) is a brand-name prescription drug for treatment of Diabetes Mellitus, Non-Insulin-Dependent. BYETTA is a glp-1 receptor agonist. It is available in the form of subcutaneous injection.
See full Prescribing Information for important safety information and clinical studies.
Cash price for 30-day supply is $900-1100.
No saving program is found for BYETTA.
Other alternatives to BYETTA may include:
